1,648 reports of this reaction
3.1% of all DESVENLAFAXINE SUCCINATE reports
#6 most reported adverse reaction
FATIGUE is the #6 most commonly reported adverse reaction for DESVENLAFAXINE SUCCINATE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 1,648 FDA adverse event reports linking DESVENLAFAXINE SUCCINATE to FATIGUE. This represents approximately 3.1% of all 53,036 adverse event reports for this drug.
Patients taking DESVENLAFAXINE SUCCINATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DESVENLAFAXINE SUCCINATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DESVENLAFAXINE SUCCINATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,648 FDA reports for DESVENLAFAXINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.1% of all adverse event reports for DESVENLAFAXINE SUCCINATE, making it a notable side effect.
If you experience fatigue while taking DESVENLAFAXINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.